COVID-19 activity in the community may affect how facilities and providers make decisions about testing, operations and personal protective equipment (PPE). This page includes guidance and information for health care providers, nursing homes and other long-term care facilities to make decisions based on measures of community-level burden.
Routine Testing of Staff
Routine staff testing is required for CMS-certified nursing homes. CMS established minimum testing frequencies based on county positivity rate, but these may be supplemented by recommendations from the Department of Health or the Department of Disabilities, Aging and Independent Living.
|Community COVID-19 Activity||County Positivity Rate||Minimum testing frequency|
|Low||<5%||Once a month|
|Medium||5% - 10%||Once a week|
|High||>10%||Twice a week|
For more information, see CMS Memo QSO-20-38-NH: Long-Term Care Facility Testing Requirements.
Long Term Care Guidance for Operations During COVID-19 Health Emergency, from the Department of Disabilities, Aging and Independent Living, in consultation with the Department of Health, identifies phases of operation that are based on the community burden of COVID-19 and cases within a facility. Each phase outlines visitation guidance, congregate activity limits, and testing requirements that apply to all long-term care residential facilities (nursing homes, residential care homes, assisted living residences, and therapeutic community residences).
The phases correspond to county positivity rates. Facilities should monitor their county positivity rate at least every other week. Community incidence should also be considered when making decisions about proactive testing, visitation, and activities within a facility.
Use the CDC's Antigen Test Interpretation flow chart which has the most current guidance to help you interpret the antigen test.
Find more guidance on antigen testing from the CDC.
Encounters with asymptomatic or presymptomatic patients with COVID-19 are more likely in the context of moderate (400-799 cases/million) or substantial (800+ cases/million) community transmission. In such instances, the use of universal eye protection reduces the potential for high-risk exposure (and exclusion from work and quarantine recommendations) among providers.